February 18, 1992, NIH Record, Vol. XLIV, No. 4

Total Page:16

File Type:pdf, Size:1020Kb

February 18, 1992, NIH Record, Vol. XLIV, No. 4 February 18, 1992 Vol. XLIV No. 4 "Still U.S. Depanment of Health The Second and Human Services Best Thing About Payday" National Institutes of Health Simple Solution Means Much e 'Think Big' Hole in the Wall Frees Worker NIH Launches African-American History Celebration By Anne Barber By Carla Garnett What does the term reasonable accom­ modation mean? To Betty Dyess of NIAID's About 20 years ago in inner-city Detroit, Division of Extramural Affairs committee an impoverished fifth grader preened under his management office, it means having a window teacher's tongue-in-cheek praise. Congratula­ cut through the partition shared by her tions were in order: The student had just coworker, Virginia Wilson. This window earned a D in math instead of the flunking allows Dyess, who is hearing impaired, to grade he had managed in nearly every other communicate with her colleague. subject. "Without this open window," says Dyess, The self-described "class dummy" says he "I would find the job very difficult. I would remembers feeling pretty good about his then have to run back and forth between our short, but abominable academic career. He offices." knew he was the dumbest student in class and Wilson explains, "The window also makes his classmates and the teacher knew it as well. us more accessible to visitors. At a glance I He would return home to a tenement overrun can screen visirors if Betty is out or working with "dog-size" water rats and king-size on her computer and is not aware of someone roaches, and he would play outdoors a while, coming up behind her back." then watch hours of television until bedtime. Claudia Goad, committee management On Feb. 10, that student, Dr. Benjamin S. officer, credits Mike Crumly, the division's Carson, graduate of Yale University and the administrative officer, with solving the prob­ University of Michigan Medical School and Neurosurgeon Ben Carson gave the keynote address lem. "Mike has been involved in moving the now direcror of pediatric neurosurgery at at NIH's Black History opening program. entire division over to Executive Blvd. for the Johns Hopkins, delivered the keynote address past year," she states. "When it came our turn for the opening of NIH's 1992 Black Hisrory turned that fifth grader's life around. His to leave Westwood Bldg., where we had been Month program, "African-American Roots: advice was deceptively simple: Think big. for the past 6 years, we immediately saw Explore New Worlds, Pre-Columbus to the A world renowned neurosurgeon who problems with our space. We explained our Space Age." helped develop the hemispherectomy tech­ concerns to Mike and he listened. He came up To the capacity crowd--comprised largely nique that was first used to separate a set of with a solution and had the work completed of school-age youngsters-assembled in Masur (See HISTORY, Page 9) within 2 weeks. Auditorium, Carson gave the formula chat (See ACCOMMODATION, Page 4) Occupational Therapist Uses Dean of OD Staff Computers To Boost Patients NIH Communications Chief Storm Whaley Retires By Anne P. Enright Shepherd By Rich McManus For patients with depression, finding the Srorm Whaley, NIH associate director for motivation to do even the simplest tasks can communications for five NIH directors and be monumentally difficult. Glenda Grogan, an four acting directors since his arrival in July occupational therapist in the Clinical Center, 1970, retired Feb. 3. Several hundred has a unique solution. She uses a tool that, NIH'ers, among them a handful of past direc­ although increasingly common in biomedicine, tors, turned out to bid him farewell at a is an oddity in clinical treatment for those reception Jan. 29 in Wilson Hall. with depression and other mental health "To say that you know Storm Whaley is to patients: a personal computer. join a very privileged group," said Dr. Grogan, of the rehabilitation medicine Bernadine Healy, NIH director. "He department, uses the technical help of the embodies so much that is right and gentle Division of Computer Research and Technol­ about us. He is the communicator par ogy in developing and operating a Computer excellence. " Training Program for some CC patients. "I Healy praised Whaley as a gifted part-time am certainly very excited about the Computer painter, a prodigy at mathematics, a writer, Training Program because I've seen patients singer, radio announcer, pilot and ground who are chronically depressed seem motivated instructor. But most of all, she said, "Storm by it," she said recently. Whaley knows how to be your friend. He has Storm Whaley, NIH associate director for communi­ The program operates on an individual been of inestimable value to me. I trusted his cations for the past 21 years, five directors and four basis-patients choose projects and set their calm, confident advice and appreciated his acting directors, retired Feb. 3. Hundreds of own goals-using two Macintosh computers clarity of view. He is an absolutely first-rate NIH'ers wished him well at a reception Jan. 29 in and a printer. "The Macintosh appears to be a man and intellect. I'm happy I was able to get Wilson Hall. wonderful therapeutic tool for mental health to know this extraordinary man who gave so patients," remarks Grogan. "The creativity much to NIH." by the quality of the staff, and one of the and humor built into the Macintosh programs Added Healy's predecessor, Dr. James B. gems was Storm Whaley." make it a particularly refreshing tool for Wyngaarden, "When I came to NIH as direc­ Admitting that it was difficult to speak in patients struggling with depression." Group tor 10 years ago, I was immediately impressed (See WHALEY, Page 6) (See THERAPY, Page 10) page 2 The Record February 18, 1992 NINDS Sponsors Second Conference on the Chemical Research Poster Day Senses To Be Held, Mar. 2-3 Scientists from NINDS' intramural program On Mar. 2 and 3, the National Institute on will exhibit some of their latest research find­ Deafness and Ocher Communication Disorders ings on the brain and nervous system at the will sponsor a 2-day conference on "Develop­ NINDS Research Poster Day, Tuesday, Feb. ment, Growth and Senescence in the Chemical 25 at the Clinical Center from 9 a.m. to 4 Senses." p.m. The event is part of the institute's ongo­ The conference will focus on complex basic ing Decade of the Brain activities. and clinical questions of how a person's sense More than 100 posters illustrating recent of smell and taste grow, change and age. advances in basic and clinical neurological sci­ Genetic and molecular mechanisms as well as ences will be on display in the Bldg. 10 the effects of environmental factors on the Visitor Information Center. Attendees can chemosenses will be discussed. An interna­ meet with NINDS scientists, who will be on tional group of scientists will present research hand to answer questions about their research from a wide range of disciplines including from 11 a.m. to 1 ·p.m. NIH employees are molecular biology and behavioral science. Cur­ invited to view the posters and take advantage rent research, new techniques and opportunites of this unique opportunity to talk with for future research will be explored. Because so NINDS scientists displaying their work. many disciplines are involved in the study of Dr. Norka Ruiz Bravo recently was appointed a Interested representatives from private the chemosenses, this meeting is a rare oppor­ program administrator in the Genetics Program industry, academia, and state and local gov­ tunity for the direct exchange of information Branch, NIGMS. Previously a scientific review ernments are also welcome to attend and are on these diverse yet related entities. administrator in NIGMS' Office of Review encouraged to explore potential collaborations The conference, cosponsored by NIA and Activities, she will now administer grants relating with federal scientists. NICHD, will be held in Masur Auditorium, to the molecular mechanism of gene control. Prior to The exhibit represents an extraordinary Bldg. 10. For registration and information joining NIH, Ruiz Bravo was an assistant pro­ opportunity for NIH employees and ochers to contact NIDCD, 496-7243; TDD: fessor in the departments of urology and cell biology become acquainted with the diversity of neu­ 402-0252. 0 at Baylor College of Medicine. A native of Peru, rological sciences research conducted within she received her undergraduate degree from Goucher College in Towson, Md., and her Ph.D. from the NINDS intramural program. Yale University. As part of the poster day, NINDS is spon­ soring a "Distinguished Alumnus Guest Normal Volunteers Needed Lecture" to be given by Dr. Eric R. Kandel, a NIAAA is seeking normal volunteers ages senior investigator of the Howard Hughes 15 and older for study on connections between Medical Institute and University professor at EEG readings and predisposition toward per­ the Center for Neurobiology and Behavior, sonality traits. Must have both parents living Columbia University College of Physicians & and at least three siblings available for study. Surgeons. All subjects will be paid for participation. For The NIH Record Kandel will speak on "Genes, Nerve Cells, further information call Claudia Harris, Published biweekly at Bethesda, Md., by the Editorial and the Remembrance of Things Past" at 1 496-7874 after 6 p.m. Leave a message Operations Branch, Division of Public Information, for the p.m. in Masur Auditorium, Bldg. 10. For including phone number and convenient time information of employees of the National Institutes of Health, Department of Health and Human Services, and more information, call Jan Heffernan, for return call. 0 circulated to nonemployees by subscription only through 496-5468.
Recommended publications
  • NINR History Book
    NINR NATIONAL INSTITUTE OF NURSING RESEARCH PHILIP L. CANTELON, PhD NINR: Bringing Science To Life National Institute of Nursing Research (NINR) with Philip L. Cantelon National Institute of Nursing Research National Institutes of Health Publication date: September 2010 NIH Publication No. 10-7502 Library of Congress Control Number 2010929886 ISBN 978-0-9728874-8-9 Printed and bound in the United States of America TABLE OF CONTENTS Preface The National Institute of Nursing Research at NIH: Celebrating Twenty-five Years of Nursing Science .........................................v Acknowledgments ..................................................................................................ix Chapter One Origins of the National Institute of Nursing Research .................................1 Chapter Two Launching Nursing Science at NIH ..............................................................39 Chapter Three From Center to Institute: Nursing Research Comes of Age .....................65 Chapter Four From Nursing Research to Nursing Science ............................................. 113 Chapter Five Speaking the Language of Science ............................................................... 163 Epilogue The Transformation of Nursing Science ..................................................... 209 Appendices A. Oral History Interviews .......................................................................... 237 B. Photo Credits ........................................................................................... 239
    [Show full text]
  • May 30, 1989, NIH Record, Vol. XLI, No. 11
    May 30. 1989 Vol. XU No. 11 U.S. Departmenr of Health and H uman Services National Institutes of Health NIH's 'Legislative Father' Director Reflects on 7½ Years at NIH Bldg. 31 Renamed; ll)' Rich McManus Honors Claude Pepper Par/ one ofa two-part ,eries Under rainy skies char were brighcened Sometime chis sumrner, NIH direccor Dr. purchasing power. During his 7 'Ii-year rerm, considerably by the music of rhe Marine Band, ]tunes B. Wyngaarden will relinquish whar rhc institutes have realized a 35-40 percent Bldg. 31 was recently renamed in honor of many consider the most powerful post in gain in purchasing power. Rep. Claude Denson Pepper (D.-Fla.). The American medicine. He will leave behind a Other statistics salure his dedication to legislative sponsor of all bur one NIH legacy t hat is ac once easily computed and stabilizing and promoting rhc advance of insciruce, Pepper was hailed as NIH's hard ro fathom. biomedical research. Boch the number and "legislative father." Easy co grasp are rhe achievements chat d uration of investigator-initiated research proj­ Hospitalized in recent weeks for a stomach numbers can capture. Arriving as dircccor on ect grams are up, a robust conscrucrion ailment, Pepper, 88, was unahle to attend the Feb. I, I 982 (though nor formally inducted program is under way on campus, vigorous ceremony rededicaring rhe 28-year-old office until Apr. 30), he gave himself the goal of and talented staff occupy virtually all top building. Speaking in his place was Sen. doubling the NIH bL1dget during his term.
    [Show full text]
  • Duke Health Named Professor
    advancing innovation + discovery Duke Health Named Professorships DUKE HEALTH to establish endowed scientific opportunities professorships are gifts here and around the world. Endowed professorships that last forever. Once Great universities succeed are the highest academic inaugurated, they continue on the strength of the honor that the Duke in perpetuity, passing in partnerships they form University School of time from one exceptional with their supporters and Medicine or School of faculty member to the benefactors. Everyone who Nursing can bestow upon a next. Every endowed establishes an endowed faculty member. professorship is both a professorship at Duke These prestigious profound honor for the Health joins with us in positions honor our most faculty member who holds our mission to deliver accomplished physician- it and a meaningful legacy tomorrow’s health care and nurse-scientists and to the visionary benefactor today, accelerate research clinicians. They celebrate who establishes it. and its translation, and Duke University those who demonstrate That legacy is evident in the create education that A. Eugene Washington, extraordinary achievement pages that follow, as we is transforming. We are School of Medicine in advancing scholarship, MD, MSc profile our philanthropic deeply grateful for these Introduction Chancellor for Health Affairs, science, and human Dean Mary E. Klotman, MD 5 Duke University partners who have partners, who, as you health. And perhaps most President and CEO, generously invested in will read, have propelled importantly, they nurture Duke University Health System endowed professorships our professors and our Nobel Prize Recipients 6 innovation, discovery, at Duke Health. They institution to even greater and the expansion of the have demonstrated heights of excellence and Donors & Professors 8 boundaries of knowledge.
    [Show full text]
  • Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006
    Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006 JM: The information I am about to give you and your response will now be recorded. My name is Jennifer Midura and I am a student at Duke University. I am in a course on the history of genomics that includes oral history. One goal is to produce a written transcript of interviews with important figures in genomics. Some of the interviews may be archived or made public through a website. I selected you as the person I would like to interview. The interview should last about 45 minutes. Your participation in this interview is strictly voluntary, and you may withdraw at any time. You do not have to answer every question asked. The information that you provide will be “on the record” and may be attributed to you. This interview is being recorded and I will take written notes during the interview. The interviews that are posted publicly will be archived as a history resource. If you prefer that the interview be used only for the course and not made public, please indicate this. One risk of this study is that you may disclose information that later could be requested for legal proceedings. Or you may say something that embarrasses you or offends someone else when they read it on a public website. The benefit of participating in this study is ensuring that your side of the story is properly portrayed in the history of genomics.
    [Show full text]
  • Commemorative Book Letter from Mary Woolley
    About Research!America Research!America is the nation’s largest 501(c) (3) public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by member institutions, organizations and businesses that together represent the voices of more than 100 million Americans. Our public opinion polls, advocacy programs and publications reach the public and decision makers to help advance medical, health and scienti c research. 1101 King Street, Suite 520 Alexandria, VA 22314-2960 703.739.2577 phone 703.739.2372 fax www.researchamerica.org 25th Anniversary Commemorative Book Letter from Mary Woolley In the late 1980s, visionary champions for medical research convened to address the widening gap between the extraordinary promise of research and the less-than-robust support it was then garnering from the public and its elected representatives. These leaders believed that allowing this gap to continue would be detrimental to Americans for years to come. They resolved to form a national alliance with a broad membership base and a singular focus on advocacy for research. Today, the Research!America alliance represents the voices of more than100 million Americans from academia, independent research institutes and hospitals, scientific societies, state and local organizations, voluntary health groups, and pharmaceutical, biotech and medical device manufacturing industries. In partnership with our mem- bers, we have successfully secured more funding for our nation’s federal health agencies; advocated for smarter policies that empower, rather than impede, private sector innovators; and most importantly, helped unleash scientific opportunity, leading to unprecedented medical progress.
    [Show full text]
  • April 27, 1982, NIH Record, Vol. XXXIV, No. 9
    The NIH Record U.S. Department April 27 National of Health 1982 Institutes and Vol. XXXIV of Human Services No. 9 Health Dr. Martin Rosenberg NIH-Produced Film on Genital Herpes Wins Flemming Award Generates Considerable Public Interest Dr. Martin Rosenberg, chief of the cellu­ lar regulation section, NCI Laboratory of Recognizing the critical need for public Biochemistry, received the 33rd annual Ar­ education about genital herpes, the Office thur S. Flemming Award on Apr. 23 in of Research Reporting and Public Re­ Washington, D.C. sponse, National Institute of Allergy and The award was presented by Dr. Flem­ Infectious Diseases, and the NIH Audiovis­ ming, former DHEW Secretary (1958-1961), ual Branch have produced Jennifer: A Re­ and by Dr. Thomas E. Malone, Acting NIH vealing Story of Genital Herpes. This 28- Director. minute film shares the experience of a young woman striving to cope with her own case of genital herpes. Segments of this film have been tele­ vised on national network shows and also on local TV news and public service pro­ grams. Jennifer has been made available to physicians, health facilities, schools and In the film, Jennifer chats with Dr. Straus, civic groups on short-term loans. The re­ whose research group has successfully used sponse to initial promotional efforts has acyclovir to prevent recurrence of herpes virus been overwhelming. To date, more than infection. 500 loan requests from schools had to be edge and understanding of the signs and booked for the fall semester. symptoms of this disease, many people Infection with the virus causing genital with herpes unintentionally transmit it to herpes is on the upswing, reaching epi­ others.
    [Show full text]
  • Human Genome Project
    MARCH 2002 Managing “Big Science”: A Case Study of the Human Genome Project W. Henry Lambright Professor of Political Science and Public Administration and Director, Center for Environmental Policy and Administration The Maxwell School Syracuse University The PricewaterhouseCoopers Endowment for New Ways to Manage Series Ways New The Business of Government NEW WAYS TO MANAGE SERIES Managing “Big Science”: A Case Study of the Human Genome Project W. Henry Lambright Professor of Political Science and Public Administration and Director, Center for Environmental Policy and Administration The Maxwell School Syracuse University March 2002 1 TABLE OF CONTENTS Foreword..............................................................................................3 Executive Summary ..............................................................................4 The Human Genome Project Today......................................................6 The Human Genome Project: A Management Case History ..............10 Conceptualization, 1980–86 ..........................................................11 Adoption, 1986–90 ........................................................................13 Initial Implementation, 1990–93 ....................................................15 Maintaining Momentum and Growing, 1993–98 ..........................17 Reorientation, 1998–2001..............................................................20 Conclusions........................................................................................27 Goals ............................................................................................27
    [Show full text]
  • History of the Human Genome Project (HGP) and Subsequent Attempts to Integrate Scans of People’S Genomes Into Healthcare in Britain and the USA
    History of the Human Genome June 2010 This briefing is based on a timeline of key events in the history of the Human Genome Project (HGP) and subsequent attempts to integrate scans of people’s genomes into healthcare in Britain and the USA. The history shows that: Claims that human genome sequencing will be useful to predict who develops common diseases are false and originate from spurious findings published by tobacco-funded scientists. Nobel Prizewinner Sydney Brenner had secret meetings with British American Tobacco (BAT) in 1988 and 1990, in an attempt to secure funding for the Human Genome Project, and the Medical Research Council (MRC) jointly funded much of the spurious research. Leading scientists at the US National Institutes of Health (NIH) also endorsed the false findings in journals and the press. Other scientists who received tobacco industry research funding (for unrelated projects) included Nobel Prizewinner Harold Varmus – recently reappointed by President Obama to run the US National Cancer Institute – and Kari Stefansson, the President of pioneering gene test company DeCode Genetics. The food and pharmaceutical industries have also promoted false claims that human genome sequencing will predict big killer diseases, in an effort to expand the market for healthcare products to large numbers of healthy people and to confuse people about the role of unhealthy processed foods in hypertension, type 2 diabetes and obesity. False claims about health benefits from sequencing the genomes of whole populations led to the £12 billion decision by Tony Blair to centralise electronic medical records in the NHS. Billions in taxpayers’ money has been wasted in both Britain and the USA, and medical privacy has been jeopardised, in an attempt to create the vast databases of electronic medical records linked to DNA that will supposedly allow scientists to ‘predict and prevent’ disease.
    [Show full text]
  • Minutes of the National Advisory Council for Nursing Research
    Department of Health and Human Services National Institutes of Health National Institute of Nursing Research Minutes of the National Advisory Council for Nursing Research September 17–18, 2019 The 99thmeeting of the National Advisory Council for Nursing Research (NACNR) was convened on Tuesday, September 17, 2019, at 12:00 p.m. in Conference Room D, Building 45, Natcher, National Institutes of Health (NIH), Bethesda, Maryland. The first day of the meeting was an open session that started at 12:00 p.m. and adjourned that same day at 4:30 p.m. The closed session of the meeting, which included consideration of grant applications, was convened on Wednesday, September 18, 2019, at 9:00 a.m. and continued until adjournment at 12:15 p.m. Dr. Ann Cashion, Acting Chair, NACNR, presided over both sessions of the meeting. OPEN SESSION I. CALL TO ORDER, OPENING REMARKS, COUNCIL PROCEDURES, AND RELATED MATTERS—Dr. Ann Cashion, Acting Director, National Institute of Nursing Research (NINR) Dr. Cashion called the 99th meeting of the NACNR to order and welcomed all Council members, visitors, and staff. She introduced new Council members Drs. Peter Lewin and Eun-Ok Im and noted the absence of Council member Dr. Jeffrey Kelly. Conflict of Interest and Confidentiality Statement Dr. Nara Gavini, Acting Executive Secretary, NACNR, and Chief, Office of Extramural Programs, NINR, noted that the meeting was being webcast. He reminded attendees that NIH is a smoke-free campus. Dr. Gavini asked Council members to update their addresses on the meeting roster circulated during the meeting. Dr. Gavini referred to the conflict of interest and confidentiality statements provided in the Council materials and indicated that specific instructions would be provided at the beginning of the closed session on Wednesday.
    [Show full text]
  • March-April 2009 Capsules from Keystone Living History
    March-April 2009 WWW.IAVIREPORT.ORG | VOLUME 13, NUMBER 2 Capsules from Keystone FIRST IN A SERIES Living History Anthony Fauci on The Quest for a Vaccine “ We are living through one the most devastating pandemics ever to confront human civilization ” EDITor’s LETTER I am excited to introduce the inaugural installment of a new series, which we are calling “A Living History of AIDS Vaccine Research.” Its purpose is to provide perspective on historical moments in the quest for a vaccine, as well as insight into what lies ahead, as told by some of the leading researchers and policymakers in the field. We could not think of a better person to launch this series than Anthony Fauci, who has served as director of the National Institute of Allergy and Infectious Diseases (NIAID) for the past 25 years. Fauci has been immersed in the AIDS pandemic ever since the first cases were described 28 years ago. He was involved in the development of the first antiretrovirals to treat HIV infection and has played a pivotal role in AIDS vaccine research and development—from his early decision not to fund the first Phase III trial of an AIDS vaccine candidate to establishing the Vaccine Research Center at NIAID. iHe’s been one of the most vocal advocates and ardent supporters of the need for an AIDS vaccine and oversees a budget of US$460 million dedicated to AIDS vaccine research and development, 30% of NIAID’s overall HIV/AIDS budget. Whether Fauci is behind the podium at a conference or meeting with activists, he always eloquently captures both the current status of research and the human toll and devastation wrought by AIDS.
    [Show full text]
  • Physician-Scientist Workforce Working Group Report.Pdf
    National Institutes of Health Physician-Scientist Workforce Working Group Report June 2014 In a word, I consider hospitals only as the entrance to scientific medicine; they are the first field of observation which a physician enters; but the true sanctuary of medical science is a laboratory; only there can he seek explanations of life in the normal and pathological states by means of experimental analysis.1 Claude Bernard, 1865 1 Bernard, Claude, An Introduction to the Study of Experimental Medicine (Dover edition 1957; originally published in 1865; first English translation by Henry Copley Greene, published by Macmillan & Co., Ltd., 1927 i The Physician-Scientist Workforce Working Group David Ginsburg, MD, Co-Chair Rena N. D’Souza, DDS, PhD James V. Neel Distinguished University Professor and Dean, School of Dentistry Professor University of Utah Departments of Internal Medicine, Human Salt Lake City, UT Genetics, and Pediatrics and Communicable Diseases James G. Fox, DVM Howard Hughes Medical Institute Professor and Director of the Division of Comparative University of Michigan Medical School Medicine Ann Arbor, MI Professor, Department of Biological Engineering Massachusetts Institute of Technology Cambridge, MA Sherry Mills, MD, MPH, Co-Chair Director, Office of Extramural Programs Helen H. Hobbs, MD National Institutes of Health Investigator, Howard Hughes Medical Institute Bethesda, MD Professor of Internal Medicine and Molecular Genetics University of Texas Southwestern Medical Center Susan Shurin, MD, Co-Chair Dallas, TX Deputy Director, National Institute of Heart, Lung and Blood Ann R. Knebel, RN, PhD, FAAN National Institutes of Health Deputy Director Bethesda, MD National Institute of Nursing Research National Institutes of Health Nancy Andrews, MD, PhD Bethesda, MD Dean, Duke University School of Medicine Vice Chancellor for Academic Affairs Elaine Larson, RN, PhD, FAAN, CIC Nanaline H.
    [Show full text]
  • Gisler Et Al the Human Genome Project 20100315
    Exuberant innovation: The Human Genome Project Monika Gisler1, Didier Sornette2,3 and Ryan Woodard2 1ETH Zurich, D-ERDW, NO, CH-8092 Zürich, +41 78 919 5058 [email protected] (corresponding author) 2ETH Zurich, D-MTEC, Chair of Entrepreneurial Risks, Kreuzplatz 5, CH-8032 Zurich [email protected]; [email protected] 3Swiss Finance Institute, University of Geneva, 40 blvd. du Pont d’Arve, CH-1211 Geneva 4 “And all this back and forthing over who did what and what strategy was used and which money was public and which was private is probably going to sink below the radar screen.” (Francis Collins)1 “The prevailing view is that the genome is going to revolutionize biology, but in some way, it’s overhyped. In the end, the real insights are coming from individuals studying one gene at a time in real depth.” (Gerald Rubin)2 Abstract We present a detailed synthesis of the development of the Human Genome Project (HGP) from 1986 to 2003 in order to test the “social bubble” hypothesis that strong social interactions between enthusiastic supporters of the HGP weaved a network of reinforcing feedbacks that led to a widespread endorsement and extraordinary commitment by those involved in the project, beyond what would be rationalized by a standard cost-benefit analysis in the presence of extraordinary uncertainties and risks. The vigorous competition and race between the initially public project and several private initiatives is argued to support the social bubble hypothesis. We also present quantitative analyses of the concomitant financial bubble concentrated on the biotech sector. Confirmation of this hypothesis is offered by the present consensus that it will take decades to exploit the fruits of the HGP, via a slow and arduous process aiming at disentangling the extraordinary complexity of the human complex body.
    [Show full text]